New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.

Slides:



Advertisements
Similar presentations
Slide 1 FastFacts Feature Presentation October 29, 2009 We are using audio during this session, so please dial in to our conference line… Phone number:
Advertisements

Ethics in Public Service Act Presented by Heather Lopez, Director Office of Internal Audit February 2013.
Pharmaceutical and Medical Device Manufacturer Conduct Melissa J. Lopes, Deputy General Counsel Massachusetts Department of Public Health.
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
1 The OII is here to help you! or An Introduction to Partners Policies on Interactions with Industry Office for Interactions.
European Union of Medical Specialists November 18, 2011 Conference John McLoughlin Chairman, European Medical Technology Industry Association (EUCOMED)
1 UMass Dartmouth Conflicts of Interest Policies UMass Dartmouth Liz Rodriguez February 17, 2011.
Conflict of Interest/Conflict of Commitment NCURA Region VI & VII Spring Meeting Chandler, AZ April 2005.
Conflict of Interest in Physician-Industry Relationships
Commercial support is defined as financial or in- kind contributions given by a commercial interest, which is used to pay all or part of the costs of a.
Sizewise Code of Ethics, Conflict of Interest and Disclosure HR-CECID.
Welcome Vendor Representative Orientation
Marketing to Doctors – Payments for Loyalty Julie Brill Assistant Attorney General Vermont Attorney General ’ s Office Montpelier,
Pharmaceutical Compliance Congress: “State of the States” October 27, 2008 Janice G. Cunningham Jeffrey L. Handwerker.
1 Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act.
DOCTOR / DOCTOR AND DOCTOR PATIENT RELATIONSHIPS Idara C.E,
1 UCDHS Vendor Relations Policy Development & Implementation Teresa Porter, CHC - Chief Compliance Officer David Levine, JD - Legal Counsel Allan Siefkin,
Conflict of Interest. Definition  “A conflict of interest is a situation in which financial or other personal considerations have the potential to compromise.
Conflict of Interest and Technology Transfer Sherrie Settle Assistant Director, Research Compliance Program Institutional Conflict of Interest Officer.
Conflict of Interest in Medical Research, Education, and Practice Presentation for Secretary’s Advisory Committee on Human Research Protections July 22,
Chapter 11 OFFICE MANAGEMENT.
1 Health Care Vendor Relations A new UCOP Presidential Policy Lee Giddings, M.D. Chief Compliance Officer UCSD Health Sciences May 2008 Revised: 05/05/2008.
Using IU or IU Foundation Funds IU and IUF working together for compliance and liability concerns IU Financial Policy I-330.
THE ORTHOPAEDIC SURGEON’S RELATIONSHIPS WITH INDUSTRY AAOS ETHICS COMMITTEE Kenneth C. Thomas, MD 1.
University of Florida College of Medicine, Gainesville 2012 Overview CONFLICT OF INTEREST & INDUSTRY INTERACTIONS.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
Nathan Tinker Executive Director New York Biotechnology Association New York BizBio 2009 Fighting for a Healthy Biotech Industry.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
Professionalism, Physician Payment and Conflicts of Interest Sharon Levine, M.D. Associate Executive Director Kaiser Permanente October 20-21, 2008 Beijing,
© 2008 Foley Hoag LLP. All Rights Reserved. 1 The New Massachusetts Pharmaceutical & Medical Device Marketing Regulations How to Address and Overcome Likely.
State Ethics & Lobbying Laws for Pharmaceutical and Medical Device Companies John T. Bentivoglio (202) Steve Benz
CONFLICTS OF INTEREST PRESENTED BY THE UMMC OFFICE OF INTEGRITY AND COMPLIANCE.
“Delivering Therapeutic Agents” - Marketing and Communication Strategies of Drug Companies Safura Nantogmah.
Research Conflicts of Interest: Identifying and Minimizing COI from the Perspective of Faculty July 30, 2009 PonJola Coney, MD Senior Associate Dean for.
+ Conflict of Interest in Physician-Industry Relationships.
Introduction to the Offices of Biotechnology & Business Development John L. Harb Director, Office of Biotechnology __________________________________ October.
1 University of Pittsburgh Presentation to Department of Family Medicine Outside Engagements within the Industry Relationship Policy February 8, 2010 Barbara.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Program Co-Development in CME: Where have we been? Where are we going? Workshop Facilitators: Dr. Craig Campbell Dr. Jamie Meuser September 21,
University of Pittsburgh Presentation to Schools of Pharmacy and Nursing: Consulting Requirements within the Industry Relationship Policy Presented by.
1 Department Chairs’ Forum October 23, 2003 APM-020 and APM-025 Richard A. Luben.
+ Role of Industry in Clinical Care, Research, and Education.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
An Educational Session on HSC OP 10.27, Health Care Vendor Interactions April 20, 2009.
1 Continuing Medical Education and Industry Sponsorship The Pharma, Biotech and Device Colloquium Princeton, NJ June 7, 2005 Julie K. Taitsman, M.D., J.D.
Conflicts of Interest Scenarios: Decision Path Norma Houston 2011 Health Directors’ Legal Conference Continue.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
The Physician - Pharma Relationship.  Is very old and very close  But are the goals of pharmaceutical companies and medicine the same?
Emory School of Medicine – VAMC Faculty Relationships Claudia R. Adkison, J.D., Ph.D. Executive Associate Dean Administration & Faculty Affairs Emory University.
Stanford Policy – Faculty ◦ Mission: Promote public good by transferring knowledge  Consulting  Technologies arising from research These activities can.
Shelly Rose Ziegler. Overview Gifts from Industry Industry Site Access Academic Activities Questions  Growing external perception that industry has influence.
Compliance Issues in Dealing With Drug and Device Manufacturers Presentation to The Sixth Annual National Congress On Health Care Compliance Paul E. Kalb,
Outside Consulting Relationships: Compliance Review & COI Management Khrys X. Myrddin, MPPM Associate Director, COI Office, University of Pittsburgh.
Ethics in Public Service Act
eCOI electronic Conflict of Interest
Disclosure UK Talking about Transparency.
National Pharma Audioconference Revised PhRMA Code: Key Provisions
Ethics in Public Service Act
Conflict of Interest Disclosure
Conflict of Interest Disclosure
UCR PRO Reviewer Placemat
Disclosure UK Talking about Transparency.
University of Pittsburgh
Conflicts of Interest In the past 2 years I have been an employee of:
Conflict of Interest Disclosure
Industry Induction Course
Conflict of Interest Disclosure
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Presentation transcript:

New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014

Who We Are Office of Industry Relations Helen C. McLaughlin, MBA Director of the Office of Industry Relations Assistant Dean for Administration Office: Zainab R. Wurie, JD Associate Director, Contracts Office: What We Do Maintain Policies Assist faculty and staff in dealing with Industry and avoiding conflicts of interest

?? Why We Do It ?? To eliminate and/or minimize perception that industry unduly influences professional judgments in research, teaching, or patient care.  Comprehensive – “Compendium” of policies: med.emory.edu/documents/policies/Industry_Relations_Compendium.pdf

What is Meant by “Industry”?  Characteristic examples in the School of Medicine:  Biotechnology Companies  Device Manufacturers  For-Profit Educational Companies  Investment Companies  Medical Equipment Manufacturers  Medical Supplies Companies  Pharmaceutical Companies  Software Companies  Sponsored Foundations

Permitted Activities & Confidentiality Agreements  Permitted Activities Include:  Advisory Board Services  Certain Consulting Services  Certain Educational Presentations  Be aware that you must abide by the terms of confidentiality agreements.

Prohibited Activities  Speaker’s Bureaus  Promotional Activities  Putting name on a ghost-written article  Advising investment firms on research or clinical area  Activities that use Emory resources (facilities, patient data, employees, etc.)

Industry Access to Emory Facilities  Industry representatives are not permitted in public or patient care areas.  Visits from sales reps must be by appointment only.  No sales or marketing reps may attend educational or training activities in Emory buildings.  No commercial exhibits are permitted in Emory buildings.

Individual Gifts that Cannot be Accepted from Industry  Cannot accept any personal gifts regardless of value, including travel, tickets, meals, pens, pads.  Cannot accept any drug samples.  Cannot accept food or drink for School events, either on- or off-campus.  Cannot accept books or journal subscriptions  Cannot provide Faculty or Resident Travel to National professional society meetings.

Gifts to SOM from Industry  Cannot be accepted for:  Specific events or activities  Meetings or training programs  Research for a specific individual  Named activity – “The Merck Fellowship”

The Gift Game  Can you accept tote bags from a device company at a national meeting?  Can you accept pharmaceutical samples for indigent patients?  Can our residents accept textbooks from drug companies?  Can companies provide food for departmental grand rounds or conferences?  May a drug company pay for a staff member to attend a scientific meeting?